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It is currently difficult to determine the effect of oncogenic viruses on the global 
function and regulation of pathways within mammalian cells. We detail a logical step-
by-step guide to uncover viral-protein-miRNA interactions using publically available 
datasets and the network building program, Cytoscape. This method may be applied 
to identify specific pathways that are altered in viral infection, and contribute to the 
oncogenic transformation of cells. To demonstrate this, we constructed a gene 
regulatory interactome encompassing Human Papillomavirus Type 16 (HPV16) and 
its control of specific miRNAs. This approach can be broadly applied to understand 
and map the regulatory functions of other oncogenic viruses, and determine their 
role in altering the cellular environment in cancer. 
 
Availability and Implementation Cytoscape is freely available 
at https://cytoscape.org/ 
 




Viral infection is associated with multiple different types of cancer, and is a key risk 
factor in tumour development. In 2008, 15% of the 14 million identified cancer cases 
were attributed to carcinogenic infections (De Martel, et al., 2012), which highlights 
the impact of viruses on the global cancer burden. 
 
These carcinogenic viruses belong to multiple viral families, which may have 
different routes of transmission and infection. A thorough understanding of the 
molecular pathways and individual genes altered by oncogenic viruses is needed for 
the identification of targets that can be utilised for early diagnosis, prevention, and 
treatment methods. These interactions may occur between proteins, genes and non-
coding RNAs such as miRNAs. MicroRNAs are short (21nt), single-stranded, non-
coding RNAs, that are involved in the regulation of gene expression (Calin, et al., 
2002). It is estimated that greater than 60% of all protein-coding genes are regulated 
by miRNAs, with a single miRNA having the ability to control thousands of gene 
targets (Bartel, 2004; Friedman, et al., 2009). 
 
The high degree of miRNA involvement in the control of gene expression 
compounds its regulatory complexity. Previously, we mapped the interactions 
between HPV16 and miRNAs in Head and Neck Squamous Cell Carcinoma 
(HNSCC) (Mason, et al., 2018). This systematic mapping afforded a greater 
appreciation of the gene networks and was implemented in the identification 
potential regulatory mechanisms.  
 
However, the visualisation and mapping of the many thousands of gene interactions 
on a comprehensive scale is currently a challenging task. At present, there is very 
little information or suitable technical papers dedicated to the interrogation and 
mapping of viral-gene interactions. This situation is further exacerbated, as 
molecular biologists are often not experts in the analysis and visualision of large 
biological datasets. Free software packages, such as Cytoscape (Shannon, et al., 
2003; Smoot, et al., 2010), aid scientists in the visualisation and analysis of 
organism-specific molecular interactions. Specifically, Cytoscape can be used to 
map, filter, and interpret large amounts of data. Thus it may be used to uncover 
cellular processes involved in virally associated cancer development. 
 
Our described methodology utilises Cytoscape and freely-available databases for the 
analysis and visualisation of large biological datasets, and aims to integrate and map 
the interactions between viral oncogenes, their cellular targets, and the impact of 
other regulators on the resultant network. 
  
2. Building a viral miRNA human interactome 
An example of a viral-human miRNA interactome was created using the guidelines 
described in this paper. The virus of choice was HPV16, with a particular emphasis 
on the effect of the viral oncoproteins E6 and E7 on miRNA and gene regulation. For 
this interactome, we specifically focused upon hsa-miR-33a, hsa-miR-496, and 
SREBF2. This method is shown in Figure 1, and can be adapted to a specific virus 




Figure 1: Flowchart describing the construction of a virus-miRNA interactome. Each 
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Downloading Raw Human and HPV Data 
The HPV16 viral protein interactions were downloaded from the Virus Mentha 
website, and filtered in Excel by taxon 333760 (HPV16) and 9606 (H. sapiens) 
(Supplementary Figure 1A). This dataset was imported into Cytoscape as the HPV16 
interactome (Supplementary Figure 1B). This network formed the basis for the final 
viral-human interactome. The BIOGRID human interactome was loaded from the 
Cytoscape menu (Supplementary Figure 1C). This was utilised to determine the 
direct and indirect effects of the HPV16 viral oncoproteins on gene expression. 
 
Merged and Filtered Network 
Both the HPV16 interactome and BIOGRID Human genome interactome were 
merged by ‘shared name’ and ‘PSMI-25.alias’ (Supplementary Figure 2A). The 
merge type was assigned ‘Union’, as the aim of this project was to integrate the 
HPV16 genes with those of the human genome. The HPV16 viral oncoproteins, E6 
and E7, were searched for using the search network tool, and their respective nodes 
were moved away from the main interactome. This ensures for easier identification 
of the two genes for the subsequent creation of a smaller network. 
 
Both E6 and E7 were selected, along with their direct interactors to produce a 
smaller secondary network, as shown in Supplementary Figure 2B and C. This 
interactome contains the genes that directly interact with the viral oncoproteins, and 
their relationship with other human genes. It was this smaller interactome that was 
used for further network filtering and annotation, after the removal of duplicated 
edges and self-loops. 
 
Assigning Gene Names and Transcription Factors 
The gene targets of our miRNAs of interest, hsa-miR-33a and hsa-miR-496, were 
extracted from miRanda and saved as a .txt file (Supplementary Figure 3A). The 
transcription factors for hsa-miR-33a, hsa-miR-496 and SREBF2 were inferred from 
the UCSC Genome Browser and saved as a .txt file (Supplementary Figure 3B). As 
the genes in the network were labelled by Entrez ID, the DAVID name conversion 
tool was used to convert this number identifier to ‘Gene Name’ (Supplementary 
Figure 3C). These gene names were then imported into Cytoscape to correspond 
with their respective Entrez ID. This allowed for the genes to be renamed within the 
table and resultant network. 
 
Filtering the Network and Addition of miRNAs 
The gene and transcription factor lists of hsa-miR-33a, hsa-miR-496 and SREBF2 
were used to identify the appropriate nodes within the network. The secondary 
interactors of these nodes were also selected to identify potential indirect effects of 
viral oncoproteins. The selected nodes within the network are highlighted in 
Supplementary Figure 4. These interactions were used to create a new network, 
which was used for the remainder of the analysis. 
 
Within this network, nodes were added and renamed ‘miR-33a’ and ‘miR-496’. The 
colour of these nodes was modified using the style panel to differentiate them from 
the surrounding nodes. The targets and transcription factors of each miRNA were 
selected and connected to their respective miRNA through the addition of individual 
edges. This was repeated for each miRNA to visualise their regulation of the genes 
affected by HPV16 E6 and E7. 
 
Annotation of Genes 
Once the miRNAs were added and connected to their respective targets, node 
annotation was performed to visually delineate between transcription factors gene 
targets, and miRNAs. The ‘gene name’ column from the exported node table was 
used in a separate document to classify the nodes according to their connection to 
the HPV16 oncoproteins, and their characteristics (Supplementary Figure 5A). 
 
To annotate the network, the created excel table was imported into Cytoscape, and 
the samples were matched according to ‘gene name’ (Supplementary Figure 5B). 
The inclusion of these annotations allows for the alteration of the visual properties of 
the network, such as varying the colour of nodes according to their targets 
(Supplementary Figure 5C), the shape of the nodes to indicate their biological role, 
and the colour of edges according to their regulatory interaction. The final 
interactome, which includes these features, in addition to edge annotations indicating 
the direction of the transcription factor interactions, is shown in Supplementary 
Figure 6. A step by step guide is also included in the supplementary download.   
3. Discussion 
Changes to the human genome and the expression of its regulators, such as 
miRNAs, in response to viruses is highly complex. This is of particular importance in 
the case of virally driven oncogenesis, where further modifications to the regulatory 
network may compound the tumorigenic characteristics of a cell. Using the mapping 
software, Cytoscape, we developed a method to integrate the viral and human 
genome, along with miRNA regulators, which can be used to identify novel pathways 
and interactions. 
 
In our working example, it was uncovered that the overexpression of the HPV16 
oncoproteins, E6 and E7, targets specific transcription factors that possibly have a 
downstream effect on the expression levels of miR-33a, miR-496 and SREBF2. The 
identification of these pathways was made possible through the integration of the 
viral and human genome, and have since been found to have an impact in HNSCC 
(Mason, et al., 2018). Therefore, this Cytoscape methodology may be utilised in 
discovering novel viral-human interactions, but can also complement findings 
established from traditional laboratory methods. In this way, it provides a more 
rigorous and thorough understanding of the underlying pathways involved in virally 
driven carcinogenesis. 
 
Our described methodology may be applied to a wide range of viruses. This is highly 
advantageous, as it can be applied to many different areas of study within the 
virology field, and is not just limited to those related to cancer. Previously, identifying 
pathways and genes to investigate has been a case of ‘luck-of-the-draw’. However, 
this style of investigation is limited with the use of our methodology, as researchers 
can easily visualise targets of interest, thus reducing time performing initial 
investigative work. It may also be applied after certain techniques, such as 
microarrays, providing more information to the results obtained in relation to genome 
interactions and changes with experimental conditions. 
 
The addition of miRNAs adds another layer to the specificity and uniqueness to this 
methodology. The modification of gene expression by the introduction of the virus 
would have a downstream influence on the levels of miRNAs. The result of this is the 
dysregulation of target regulation, which may aid in magnifying the oncogenic or 
disease specific effect of the virus. Again, this is observed in our example, whereby 
miR-496 and miR-33a regulate genes and transcription factors that are not directly 
affected by the HPV16 oncoproteins, but are secondary interactors of E6 and E7. 
Therefore, the inclusion of miRNAs to this network analysis provides a broader and 
more complete view of cellular changes through the addition of information on the 
downstream effects on genes that are not direct targets of the virus. Also, to our 
knowledge, no methodology has been previously published describing the 
integration of the viral and human genome with miRNA interactions, establishing our 
method as holistic and unique. 
 
Although this method provides a structured way of both determining and visualising 
the impact of viruses on miRNAs and proteins within a cell, it does have several 
limitations. For one, the inclusion of large amounts of data and information to the 
network masks any potential functional pathways that may have a role in virally-
induced disease. Thus, large interactomes are harder to visualise and interpret. On 
the other hand, filtering down a larger network may introduce unintentional bias 
through the selection of genes that have a specific function, for example, 
transcription factors. This has the potential to exclude other important pathways that 
are altered by the virus, which may otherwise be identified. Therefore, several 
aspects of the network details need to be considered if the filtered network is to 
accurately reflect the pathways affected by viral expression. 
 
The use of Cytoscape plug-ins may provide more information that is useful in 
determining influential viral targets, their regulation, and the identification of 
diagnostic or prognostic biomarkers. Although not applied in our example 
interactome, altering the size of the nodes according to their number of connecting 
edges, termed degree, is one method to determine key players within the created 
network. Additionally, the use of Gene Ontology (GO) analysis using plug-ins such 
as BiNGO (Maere, et al., 2005), allows for the identification of molecular and cellular 
pathways that are most affected by the introduction of the virus. By gathering more 
information about the network, targets can be included or excluded for further 
experimental analysis, which increases the chance of selecting a highly involved 
gene or miRNA for further study. 
 
Overall, we established a method using Cytoscape to create and visualise 
interactions that occur between known viruses and the human genome, and the 
impact of miRNAs on these interactions. Our described method will enable 
researchers to more easily identify targets and pathways of interest in the context of 
human viral infection and the development of disease.  
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